Trial intelligence / Profile preview

Autologous MSCs for Rotator Cuff Tears

NCT01687777Phase 2Unknown

Sponsor
Hospital Clínico San Carlos
Start
May 2010
Primary completion
Jun 2013
Modality
Stem Cell Therapies
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of mesenchymal stem cells in rotator cuff tear (2 arms), sponsored by Hospital Clínico San Carlos. Primary endpoint: Constant Shoulder Score at 1 year. Status: unknown.

02

Drugs

mesenchymal stem cells
03

Conditions

rotator cuff tear

Beyond the preview

Go deeper on NCT01687777.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01687777.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call